口服避孕药和喘发作风险:一个基于人口的队列研究
Bohee Lee1,2, Amir Reza Rafati Fard3,2, Ernie Wong1
1National Heart and Lung Institute, Imperial College London, London, UK.
ERJ open research
|October 29, 2025
概括
只有孕激素的药丸 (POP) 与患有特定喘表型,年龄较小和皮质类固醇使用较低的女性喘发作增加有关. 联合口服避孕药与喘发作没有关联.
科学领域:
- 生殖健康 生殖健康
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性激素对喘恶化的影响尚未完全理解.
- 口服避孕药 (OCPs) 严重改变性激素水平,提供了一个独特的模型来研究它们对喘的影响.
- 在使用OCP的女性中,喘发作需要进一步调查.
研究的目的:
- 调查口服避孕药 (OCP) 使用与喘发作之间的关联.
- 为了区分联合口服避孕药 (COCs) 与仅含孕激素的药丸 (POPs) 对喘恶化的影响.
- 为了确定OCP-喘发作关系的潜在修饰因素.
主要方法:
- 一项使用英国初级保健数据 (2004-2020年) 的队列研究,针对18-50岁的喘女性.
- 从未使用者与COCs和POPs的新用户的比较,使用治疗权重的逆概率和Cox比例危险模型.
- 按年龄分层,BMI,血中乙氨基酸水平和皮质类固醇使用以确定效果修饰剂.
主要成果:
- 结合口服避孕药 (COC) 使用和喘发作 (加权-HR 1.00) 之间没有发现显著的关联.
- 仅使用孕激素药片 (POP) 显示出喘发作增加的趋势 (加权-HR 1.11),特别是在年轻的女性,患有好色素,以及使用皮质类固醇较低的女性中.
- POPs和喘发作之间的关联因喘表型和皮质类固醇使用而改变,但BMI并非如此.
结论:
- 在没有雌激素的情况下开始服用仅含孕激素的药丸 (POPs) 与患喘发作的风险更高有关.
- 这种增加的风险在患有特定喘表型的妇女中尤其明显,包括酸性喘,年轻女性以及服用较低剂量的皮质类固醇的妇女.
- 这些发现凸显了需要在患有喘的妇女中仔细考虑POPs的必要性,特别是那些患有特定表型或接受不那么密集的控制治疗的妇女.
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
951
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
951
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K


